January 15, 2026

What TV gets wrong about cardiac arrest and CPR

January 15, 2026 / Patient education / InnovateMed Author / cardiac arrest

By Tarun Sai LomteReviewed by Lauren HardakerJan 15 2026 New findings indicate television CPR scenes frequently mislead viewers about who needs CPR, where cardiac arrests occur, and how CPR should be performed. Study: Out-of-Hospital Cardiac Arrest and Compression-Only CPR on Scripted Television. Image credit: Pixel-Shot/Shutterstock.com In a recent research letter published in Circulation: Population Health and Outcomes, researchers analyzed depictions of out-of-hospital cardiac arrest […]

What TV gets wrong about cardiac arrest and CPR Read More »

The stop-smoking medication varenicline may also work for cannabis use disorder

January 15, 2026 / Research update / InnovateMed Author / cannabis use disorder

Peer-Reviewed Publication Society for the Study of Addiction image: Self-reported weekly use sessions during the primary study outcome period (weeks 6-12). Data are shown as model adjusted 7-day average weekly cannabis use sessions for participants randomized to varenicline or placebo stratified by sex with standard errors. view more Credit: McRae-Clark et al., 2026, doi: 10.1111/add.70296 A

The stop-smoking medication varenicline may also work for cannabis use disorder Read More »

Researchers discover how a respiratory bacterium obtains essential lipids from the human body and targets fat-rich tissues

January 15, 2026 / Research update / InnovateMed Author / essential lipids

Peer-Reviewed Publication Institut de Recerca Sant Pau (Sant Pau Research Institute) image: Researchers Discover How a Respiratory Bacterium Obtains Essential Lipids From the Human Body and Targets Fat-Rich Tissues view more Credit: IR Sant Pau Barcelona, January 15, 2026. A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for atypical pneumonia and

Researchers discover how a respiratory bacterium obtains essential lipids from the human body and targets fat-rich tissues Read More »

From science fiction to tumor-fighting reality: are injectable nanorobots on the way?

January 15, 2026 / Research update / InnovateMed Author / Nanorobots

Peer-Reviewed Publication Science China Press image: Inspired by how a car uses an engine and a steering wheel to reach its destination, the nanorobot integrates two enzymatic functions. Urease works for propulsion by harnessing endogenous urea in bloodstream and tumor microenvironments, while catalase controls orientation by sensing the H2O2 concentration gradient typically existing in tumor microenvironments.

From science fiction to tumor-fighting reality: are injectable nanorobots on the way? Read More »

Scientists identify pre-cancerous states in seemingly normal aging tissues

January 15, 2026 / Research update / InnovateMed Author / aging

Peer-Reviewed Publication Weill Cornell Medicine A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the first time, in a study led by investigators at Weill Cornell Medicine and the New York Genome Center. The research, published Dec. 31 in Cancer Discovery, demonstrates a practical method for simultaneously measuring

Scientists identify pre-cancerous states in seemingly normal aging tissues Read More »

Advance in pulmonary mRNA vaccine development

January 15, 2026 / Research update / InnovateMed Author / pulmonary mRNA vaccine

Peer-Reviewed Publication Ludwig-Maximilians-Universität München Novel hybrid polymer nanocarriers enable effective vaccine delivery in the lungs and the targeted activation of immune cells. An LMU research team led by Professor Olivia M. Merkel, Chair of Drug Delivery at LMU, have developed a new delivery system for inhalable mRNA vaccines. Published in the journal Cell Biomaterials, the study presents a novel

Advance in pulmonary mRNA vaccine development Read More »

New blood test shows extent of brain injury after stroke – and reveals treatment effects

January 15, 2026 / Research update / InnovateMed Author / Blood test

Peer-Reviewed Publication Ludwig-Maximilians-Universität München A new blood marker reflects the extent of brain injury after an ischemic stroke and can predict patient outcomes months to years later. Strokes are a medical emergency, yet imaging can capture only snapshots of how brain damage develops in the hours and days that follow. For many other organs, blood

New blood test shows extent of brain injury after stroke – and reveals treatment effects Read More »

The “broker” family helps tidy up the cell

January 15, 2026 / Research update / InnovateMed Author / broker

Research team at Goethe University Frankfurt classifies all human E3 ligases – New opportunities for targeted protein degradation therapies Peer-Reviewed Publication Goethe University Frankfurt image: Researchers at Goethe University have elucidated the relationships among all 462 catalytic human E3 ligases; E3 ligases also support non-degradative functions. view more Credit: Ramachandra M. Bhaskara, Goethe University Frankfurt FRANKFURT.

The “broker” family helps tidy up the cell Read More »

Potential tumor-suppressing gene identified in pancreatic cancer

January 15, 2026 / Research update / InnovateMed Author / pancreatic cancer

by Tokyo University of Science edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source TUS researchers uncovered a strong link between reduced CTDNEP1 expression and pancreatic cancer progression. They found that low levels are associated with early-stage tumors, abnormalities in major cancer-related genes, and lower survival rates, suggesting that CTDNEP1 may

Potential tumor-suppressing gene identified in pancreatic cancer Read More »

Safe, low-cost Alzheimer’s drug demonstrates efficacy against sickle cell anemia

January 15, 2026 / Research update / InnovateMed Author / sickle cell anemia

by Nathalie Huber, University of Zurich edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: National Institutes of Health Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international research group led

Safe, low-cost Alzheimer’s drug demonstrates efficacy against sickle cell anemia Read More »